Resumen
Introducción
La homología entreTP53/TP63/TP73 y la localización de este último en 1p36.33, zona frecuentemente delecionada en una gran variedad de tumores del sistema nervioso, sugiere que estos genes puedan estar implicados en la patogénesis de oligodendrogliomas.
Material y métodos
Para verificar esta hipótesis, hemos realizado un análisis mutacional mediante la técnica de PCR/SSCP y secuenciación de los genesTP53/TP63/TP73 en una serie de 41 oligodendrogliomas.
Resultados
No se encontró ninguna mutación en estos dos últimos genes, pero sí una enTP53 (518 T>C, Val173Ala). El resto de los cambios nucleotídicos identificados en las secuencias correspondieron a polimorfismos.
Conclusiones
Estos datos sugieren que la inactivación mutacional de los genes de la familia deTP53 no parece desempeñar un papel en el desarrollo neoplásico de oligodendrogliomas.
Abstract
Introduction
There is considerable homology amongTP53/TP63/TP73 genes. The last of these is located at 1p36.33; a chromosome region frequently deleted in a wide variety of tumours of the nervous system. This suggests that these genes could be involved in the development of oligodendrogliomas.
Material and methods
We performed a DNA mutation study using PCR/SSCP methods and sequencing of theTP53/TP63/TP73 genes in a series of 41 patients with oligodendrogliomas.
Results
We found one mutation (518 T→C; Val173Ala) in theTP53 gene and none in theTP63 andTP73 genes. The other nucleotide changes identified corresponded to polymorphisms.
Conclusions
These data suggest that mutations of theTP53 gene family do not appear to play a significant role in the pathology of oligodendrogliomas.
Bibliografía
Reifenberger G, Kros JM, Schiffer D, Collins VP. Oligodendroglial tumors and mixed gliomas. En: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumors of the nervous system. Lyon: IARC Press, 1997; p. 37–48.
Reifenberger J, Reifenberger G, Liu L, James CD, Weschler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows a preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175–90.
Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frecuently occurs in association and may represent early oncogenic events in oligodendroglial tumours. Int J Cancer 1995;64:207–10.
Kraus JA, Koopman J, Kastel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a commom origin of oligodendrogliomas and oligoastrocitomas. J Neuropathol Exp Neurol 1995;54:91–5.
Husemann K, Wolter M, Büschges R, Boström, Sabel M, Reifenberger G. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. J Neuropathol Exp Neurol 1999;58:1041–50.
Bello MJ, de Campos JM, Vaquero J, et al.HRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas. Cancer Genet Cytogenet 2000;116: 142–7.
Chou D, Miyashita Y, Mohrenweiser HW, et al. The BAX gene maps to the glioma candidate region at 19q13.3 but is no altered in human gliomas. Cancer Genet Cytogenet 1996;88:136–40.
Bernard J, Douc-Rasy S, Ahomadegbe JC.TP53 family members and human cancers. Hum Mut 2003;21:182–91.
Hollstein M, Sidransky D, Volgeinstein B, Harris CC. P53 mutations in human cancer. Science 1991;253:49–53.
Oghaki H, Eibl RH, Wiestler D, Yasargel MG, Newcob EW, Kleihues P. p53 mutation in nonastrocytic human brain tumours. Cancer Res 1991;51:6202–5.
Levrero M, De Laurenzi V, Constanzo A, et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Science 2000;113: 1661–70.
Jost CA, Marin M, Kaelin WG. P73 in a human p53-related protein that can induce apoptosis. Nature 1997;389: 191–4.
Escalona-Zapata J. Tumores del sistema nervioso central. Cap 2. Madrid: Ed. Complutense, 1996; p. 47–96.
Rey JA, Bello MJ, Jiménez-Lara A, et al. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 1992;51:703–6.
Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC. Mutational anlysis ofp73 andp53 in human cancer lines. Oncogene 1999;18: 3415–21.
Davis PK, Dowdy SF. P73. Int J Bioch Cell Biol 2001;33: 935–9.
Hagiwara K, McMenamin MG, Miura K, Harris CC. Mutational analysis of thep63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 1999;59:4165–9.
Cairncross JG, Ueki K, Zlatescu C, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473–9.
Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Ad Cancer Res 2000; 84–7.
Fulci G, Van Meir EG. p53 and the CNS. Mol Neurol 1999;19:61–77.
Tsujimoto T, Mochizuchi S, Iwadate Y, et al. The p73 gene is not mutated in oligodendrogliomas which frecuently have a deleted region at chromosome 1p36.3. Anticancer Res 2000;20:2495–8.
Mai M, Huang H, Reed C, et al. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics 1998;51: 359–63.
Alonso ME, Bello MJ, González-Gómez P, et al. Mutation analysis of thep73 gene in nonastrocytic brain tumours. Br J Cancer 2001;85:204–8.
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;17:2426–35.
Alonso ME, Bello MJ, González-Gómez P, et al. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas [en prensa]. Cancer Genet Citogenetic 2003.
Dong S, Pang J, Poon W, et al. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropath Exp Neurol 2001;60: 808–16.
Sunahara M, Shishikura T, Takahashi M, et al. Mutational analysis ofp51A/Tap63Y/, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene 1999;18:3761–5.
Park BJ, Lee SJ, Kim JI, et al. Frequent alteration ofp63 expression in human primary bladder carcinomas. Cancer Res 2000;60:3370–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández, M.E.A., González, M.J.B., Carbonero, C.A. et al. Análisis mutacional de los genes de la familiaTP53 en oligodendrogliomas. Rev Oncol 6, 37–40 (2004). https://doi.org/10.1007/BF02710300
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02710300